tiprankstipranks
Trending News
More News >
Sutro Biopharma (STRO)
:STRO
US Market

Sutro Biopharma (STRO) Financial Statements

Compare
670 Followers

Sutro Biopharma Financial Overview

Sutro Biopharma's market cap is currently $52.60M. The company's EPS TTM is $-3.01; its P/E ratio is ―; Sutro Biopharma is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $-0.64. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 62.04M$ 153.73M$ 67.77M$ 61.88M$ 42.72M
Gross Profit$ 62.04M$ 146.91M$ 59.48M$ 52.11M$ -34.24M
Operating Income$ -238.45M$ -89.28M$ -128.94M$ -98.52M$ -71.06M
EBITDA$ -186.81M$ -67.92M$ -105.07M$ -98.52M$ -23.75M
Net Income$ -227.46M$ -106.79M$ -119.20M$ -108.67M$ -36.20M
Balance Sheet
Cash & Short-Term Investments$ 316.89M$ 375.62M$ 302.34M$ 197.94M$ 368.14M
Total Assets$ 387.21M$ 470.74M$ 406.94M$ 341.41M$ 394.11M
Total Debt$ 23.15M$ 33.63M$ 67.52M$ 57.37M$ 24.55M
Net Debt$ -167.15M$ -35.63M$ 20.26M$ 26.96M$ -181.61M
Total Liabilities$ 342.61M$ 321.09M$ 189.90M$ 88.84M$ 62.06M
Stockholders' Equity$ 44.60M$ 149.65M$ 217.05M$ 252.56M$ 332.05M
Cash Flow
Free Cash Flow$ -194.64M$ -115.93M$ -4.31M$ -97.00M$ -74.93M
Operating Cash Flow$ -191.54M$ -111.62M$ 3.55M$ -81.68M$ -67.80M
Investing Cash Flow$ 218.51M$ -3.92M$ -35.02M$ -97.31M$ 604.00K
Financing Cash Flow$ 94.05M$ 137.55M$ 48.31M$ 3.26M$ 269.25M
Currency in USD

Sutro Biopharma Earnings and Revenue History

Sutro Biopharma Debt to Assets

Sutro Biopharma Cash Flow

Sutro Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis